Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03149055
What this trial is testing

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Hematologic MalignancyMyeloproliferative Disorder
Memorial Sloan Kettering Cancer Center 99
Testing effectiveness (Phase 2)Temporarily pausedNCT01211691
What this trial is testing

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Who this might be right for
Myelodysplastic Syndrome (MDS)Myelofibrosis (MF)
Humanigen, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Early research (Phase 1)Not Yet RecruitingNCT07701889
What this trial is testing

Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic Malignancies

Who this might be right for
Hematologic Diseases
Roswell Park Cancer Institute 21
Not applicableStudy completedNCT03087227
What this trial is testing

Shared Health Information System for Febrile Neutropenia

Who this might be right for
Febrile NeutropeniaSolid TumorHematologic Neoplasms
Marie-Helene METZGER 121
Early research (Phase 1)WithdrawnNCT02871323
What this trial is testing

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Polycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary Myelofibrosis
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01162096
What this trial is testing

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Testing effectiveness (Phase 2)Study completedNCT00202917
What this trial is testing

Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University Hospital Tuebingen 61
Testing effectiveness (Phase 2)Study completedNCT01664910
What this trial is testing

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 27
Not applicableStudy completedNCT04870320
What this trial is testing

Study of Attention and Memory Treatments for Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 49
Testing effectiveness (Phase 2)Study completedNCT00397579
What this trial is testing

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesBlastic Plasmacytoid Dendritic Cell Neoplasm
University of Texas Southwestern Medical Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03399773
What this trial is testing

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Fred Hutchinson Cancer Center 31
Not applicableUnknownNCT02066025
What this trial is testing

Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test

Who this might be right for
Breast Cancer
Eventus Diagnostics Ltd 1,425
Early research (Phase 1)Study completedNCT00722488
What this trial is testing

Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma

Who this might be right for
Hematologic MalignanciesMultiple MyelomaLymphoma+1 more
Millennium Pharmaceuticals, Inc. 56
Not applicableStudy completedNCT04303091
What this trial is testing

The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematologic NeoplasmsAdvanced Cancer
Dr. Nicole Culos-Reed 19
Testing effectiveness (Phase 2)Study completedNCT00452023
What this trial is testing

Pegasys® in Patients With Myeloproliferative Diseases

Who this might be right for
Myeloproliferative Disorders
M.D. Anderson Cancer Center 83
Early research (Phase 1)Study completedNCT00304018
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 5
Not applicableStudy completedNCT04035447
What this trial is testing

Symptom Management for YA Cancer Survivors

Who this might be right for
CancerYoung AdultPain+7 more
Duke University 65
Not applicableActive Not RecruitingNCT03168815
What this trial is testing

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

Who this might be right for
ImmunocompromisedHematologic MalignancyPost Hematopoietic Stem Cell Transplant+2 more
Mount Sinai Hospital, Canada 98
Not applicableUnknownNCT04024618
What this trial is testing

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

Who this might be right for
Malignant Hematologic Neoplasm
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Next Page